Regeneron Pharmaceuticals REGN
NASDAQ REGN
$902.90 -27.77 (-2.98%)
At close: Nov 5, 2026 · 4:00 PM EST

Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026)

Updated

Regeneron Pharmaceuticals' Current Leases came in at $720 million for Q2 2026, unchanged from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026) Analysis & Trends

At the end of FY2021, Regeneron Pharmaceuticals' Current Leases was $719.7 million.

  • Current Leases carries a five-year compound annual growth rate of 41.4% (FY2016 to FY2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn -
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn -
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn -
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn -
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn -
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn -
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn -
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn -
10 Regeneron Pharmaceuticals 91.70 Bn 57.05 Bn 4.54 Bn 720.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 720.00 Mn
Jun 30, 2026 720.00 Mn
Mar 31, 2026 720.00 Mn
Dec 31, 2021 719.70 Mn
Sep 30, 2021 719.00 Mn
Jun 30, 2021 718.40 Mn
Mar 31, 2021 717.80 Mn
Dec 31, 2016 127.27 Mn
Sep 30, 2014 1.25 Mn
Jun 30, 2014 1.06 Mn
Mar 31, 2014 1.06 Mn
Dec 31, 2013 939,000.00
Sep 30, 2013 794,000.00
Jun 30, 2013 794,000.00
Mar 31, 2013 1.47 Mn
Dec 31, 2012 1.37 Mn
Sep 30, 2012 1.28 Mn
Jun 30, 2012 1.18 Mn
Mar 31, 2012 1.09 Mn
Dec 31, 2011 1.01 Mn
API Access

Regeneron Pharmaceuticals Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=REGN&period=max&api_key=YOUR_API_KEY